Methods for identifying anti-cancer drug targets

Details for Australian Patent Application No. 2006218344 (hide)

Owner Exelixis, Inc.

Inventors Ollmann, Michael Martin; Karim, Felix D.; Duyk, Geoffrey; Kopczynski, Casey; Kopczynski, Jenny; Friedman, Lori

Agent Davies Collison Cave

Pub. Number AU-A-2006218344

Parent 2001230888

Filing date 15 September 2006

Wipo publication date 12 October 2006

International Classifications

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

5 October 2006 Complete Application Filed

12 October 2006 Application Open to Public Inspection

  Published as AU-A-2006218344

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006218345-Seven up

2006218343-Apparatus for Forming and Packaging Flexible Ducting